Literature DB >> 24746860

Clinical evaluation compared to the pulse indicator continuous cardiac output system in the hemodynamic assessment of critically ill patients.

Jun Duan1, Lu-Hong Cong1, Hui Wang1, Yi Zhang1, Xiao-Jing Wu1, Gang Li2.   

Abstract

OBJECTIVE: The objective was to assess the effects of pulse indicator continuous cardiac output catheterization on the management of critically ill patients and the alteration of therapy in intensive care units.
METHODS: One hundred thirty-two patients with primary physiological abnormalities of hypotension or hypoxemia were evaluated. Prior to catheterization, physicians were asked to complete a questionnaire that collected information regarding predictions of the ranges of several hemodynamic variables and plans for therapy. After catheterization, each chart was reviewed by a panel of intensive care attending physicians to determine the possibility of altering the therapy.
RESULTS: Overall correct classification of the key variables ranged from 46.0% to 65.4%. Catheterization results prompted alterations in therapy for 45.5% of patients. The fellows were less accurate in predicting hemodynamic values for patients whose diagnoses were unknown, and the primary abnormality was hypotension. There was significant difference in the physicians' abilities to predict the hemodynamics for the subgroups with and without acute myocardial infarction. When the patients were divided into 3 subgroups by Acute Physiology and Chronic Health Evaluation II and Sepsis-related Organ Failure Assessment scores, the fellows had the most difficulty predicting the variables of the moderately ill patients in the middle subgroup, which led to the greatest percentage of therapy alterations for this subgroup; and this difference was significant.
CONCLUSIONS: The hemodynamic variables obtained from pulse indicator continuous cardiac output catheterization improved the accuracy of bedside evaluations and led to alterations in therapeutic plans, particularly among the moderately ill patients with hypotension or unknown diagnoses.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24746860     DOI: 10.1016/j.ajem.2014.03.023

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  The effects of advanced monitoring on hemodynamic management in critically ill patients: a pre and post questionnaire study.

Authors:  Azriel Perel; Bernd Saugel; Jean-Louis Teboul; Manu L N G Malbrain; Francisco Javier Belda; Enrique Fernández-Mondéjar; Mikhail Kirov; Julia Wendon; Roger Lussmann; Marco Maggiorini
Journal:  J Clin Monit Comput       Date:  2015-12-10       Impact factor: 2.502

2.  The diagnostic accuracy of clinical examination for estimating cardiac index in critically ill patients: the Simple Intensive Care Studies-I.

Authors:  Bart Hiemstra; Geert Koster; Renske Wiersema; Yoran M Hummel; Pim van der Harst; Harold Snieder; Ruben J Eck; Thomas Kaufmann; Thomas W L Scheeren; Anders Perner; Jørn Wetterslev; Anne Marie G A de Smet; Frederik Keus; Iwan C C van der Horst
Journal:  Intensive Care Med       Date:  2019-01-31       Impact factor: 17.440

3.  Effects of PICCO in the guidance of goal-directed fluid therapy for gastrointestinal function after cytoreductive surgery for ovarian cancer.

Authors:  Zhen Jiang; Jiaqi Chen; Chen Gao; Mengyuan Tan; Wei Zhang; Yanhu Xie
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 4.  Clinical examination for diagnosing circulatory shock.

Authors:  Bart Hiemstra; Ruben J Eck; Frederik Keus; Iwan C C van der Horst
Journal:  Curr Opin Crit Care       Date:  2017-08       Impact factor: 3.687

5.  Influence of injection rates of calibrating standard solution on monitoring pulse indicator continuous cardiac output.

Authors:  Chen Shu-Lan; Lan Fang-Chen; Du Zhen-Shuang; Xu Ya-Ping; Zhao Hui-Ming; Zeng Cui-Ping; Miao Yu
Journal:  Biomed Eng Online       Date:  2018-03-16       Impact factor: 2.819

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.